Association Between Mortality and Persistent Use of Beta Blockers and Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Coronary Artery Disease

Beta Blockers ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Artery Disease

Association Between Mortality and Persistent Use of Beta Blockers and Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Coronary Artery Disease

The American Journal of Cardiology ◽

10.1016/j.amjcard.2009.01.363 ◽

2009 ◽

Vol 103 (11) ◽

pp. 1518-1524 ◽

Cited By ~ 7

Author(s):

Nancy M. Allen LaPointe ◽

Yi Zhou ◽

Judith A. Stafford ◽

Adrian F. Hernandez ◽

Judith M. Kramer ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Beta Blockers ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Artery Disease

Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction

Archives of Internal Medicine ◽

10.1001/archinte.166.7.787 ◽

2006 ◽

Vol 166 (7) ◽

pp. 787 ◽

Cited By ~ 83

Author(s):

Nicolas Danchin ◽

Michel Cucherat ◽

Christian Thuillez ◽

Eric Durand ◽

Zena Kadri ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Artery Disease

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)00262-6 ◽

2003 ◽

Vol 41 (9) ◽

pp. 1529-1538 ◽

Cited By ~ 336

Author(s):

Paul G. Shekelle ◽

Michael W. Rich ◽

Sally C. Morton ◽

Col.Sid W. Atkinson ◽

Wenli Tu ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Beta Blockers ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Diabetic Status

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

The Lancet ◽

10.1016/s0140-6736(06)69201-5 ◽

2006 ◽

Vol 368 (9535) ◽

pp. 581-588 ◽

Cited By ~ 338

Author(s):

Gilles R Dagenais ◽

Janice Pogue ◽

Kim Fox ◽

Marteen L Simoons ◽

Salim Yusuf

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

Yearbook of Cardiology ◽

10.1016/s0145-4145(08)70214-4 ◽

2007 ◽

Vol 2007 ◽

pp. 346-348

Author(s):

M.D. Cheitlin

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction

The American Journal of Cardiology ◽

10.1016/s0002-9149(01)02092-6 ◽

2001 ◽

Vol 88 (11) ◽

pp. 1298-1300 ◽

Cited By ~ 69

Author(s):

Wilbert S Aronow ◽

Chul Ahn ◽

Itzhak Kronzon

Keyword(s):

Enzyme Inhibitors ◽

Beta Blockers ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Coronary Events

The effectiveness of angiotensin converting enzyme inhibitors in medicare beneficiaries with heart failure and left ventricular systolic dysfunction: results of the National Heart Care Project

Journal of Cardiac Failure ◽

10.1016/s1071-9164(03)00163-5 ◽

2003 ◽

Vol 9 (5) ◽

pp. S86

Author(s):

Frederick A. Masoudi ◽

Saif S. Rathore ◽

Yongfei Wang ◽

Edward P. Havranek ◽

JoAnne M. Foody ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Medicare Beneficiaries ◽

Care Project

A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction

European Journal of Heart Failure ◽

10.1016/j.ejheart.2004.02.002 ◽

2004 ◽

Vol 6 (7) ◽

pp. 927-935 ◽

Cited By ~ 24

Author(s):

Jawdat Abdulla ◽

Steen Z. Abildstrom ◽

Erik Christensen ◽

Lars Kober ◽

Christian Torp-Pedersen

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction

Progress in Cardiovascular Diseases ◽

10.1053/pcad.1999.0410265 ◽

1999 ◽

Vol 41 (4) ◽

pp. 265-300 ◽

Cited By ~ 21

Author(s):

Gary E Sander ◽

James J McKinnie ◽

Stanley S Greenberg ◽

Thomas D Giles

Keyword(s):

Enzyme Inhibitors ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonists ◽

Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Hyponatremia

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2013.09.004 ◽

2013 ◽

Vol 19 (11) ◽

pp. 725-730 ◽

Cited By ~ 2

Author(s):

Louise Balling ◽

Lars Kober ◽

Morten Schou ◽

Christian Torp-Pedersen ◽

Finn Gustafsson

Keyword(s):

Enzyme Inhibitors ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Converting Enzyme ◽

Efficacy And Safety ◽